A retrospective analysis of the impact of the COVID-19 pandemic on staging at presentation of patients with invasive melanoma.

J Am Acad Dermatol · 2022 · PMC9085439 · PMID 35551967

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significanceP = .240not close (p > 0.1)

The median time to recurrence from the time of initial melanoma diagnosis was more than doubled in the postpandemic cohort (60.0 vs 25.5 months), although this did not reach statistical significance ( P = .240).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.